Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial

Authors: Paul P. Tak, Andra Bălănescu, Vira Tseluyko, S. Bojin, Edit Drescher, Dan Dairaghi, Shichang Miao, Vittorio Marchesin, Juan C. Jaén, Thomas J. Schall, Pirow Bekker - Annals of the Rheumatic Diseases 2012 cited by 99